Use of cannabinoids in the treatment of epilepsy
US-12064399-B2 · Aug 20, 2024 · US
This page is not indexed by search engines while we improve data quality.
Devinsky Orrin patents
Devinsky Orrin is listed as an inventor on 65 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Devinsky Orrin |
| Total patents | 65 |
| First publication | May 26, 2015 |
| Latest publication | Aug 20, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Use of cannabidiol in the treatment of nocturnal snoring
US-2024261234-A1 · Aug 8, 2024 · US
Use of cannabinoids in the treatment of epilepsy
US-2024165048-A1 · May 23, 2024 · US
Use of cannabinoids in the treatment of epilepsy
US-11963937-B2 · Apr 23, 2024 · US
Use of cannabinoids in the treatment of epilepsy
US-2023301936-A1 · Sep 28, 2023 · US
Use of cannabinoids in the treatment of epilepsy
US-11766411-B2 · Sep 26, 2023 · US
Use of cannabinoids in the treatment of epilepsy
US-2023248664-A1 · Aug 10, 2023 · US
Use of cannabinoids in the treatment of epilepsy
US-11701330-B2 · Jul 18, 2023 · US
Use of cannabinoids in the treatment of epilepsy
US-11633369-B2 · Apr 25, 2023 · US
Precise template-free correction of brca1 mutation in human cells via genome editing
US-2023069642-A1 · Mar 2, 2023 · US
Recent patents
Latest publications not already listed above.
Use of cannabidiol in the treatment of nocturnal snoring
US-2023032502-A1 · Feb 2, 2023 · US
Use of cannabinoids in the treatment of epilepsy
US-2022395471-A1 · Dec 15, 2022 · US
Use of cannabinoids in the treatment of epilepsy
US-2022387348-A1 · Dec 8, 2022 · US
Use of cannabinoids in the treatment of epilepsy
US-2022378717-A1 · Dec 1, 2022 · US
Electroencephalography (eeg) electrode arrays and related methods of use
US-2022370805-A1 · Nov 24, 2022 · US
Use of cannabinoids in the treatment of epilepsy
US-11446258-B2 · Sep 20, 2022 · US
Cannabinoids in the treatment of epilepsy
US-2022202738-A1 · Jun 30, 2022 · US
Interneuron-specific therapeutics for normalizing neuronal cell excitability and treating dravet syndrome
US-2022195457-A1 · Jun 23, 2022 · US
Use of cannabinoids in the treatment of epilepsy
US-11357741-B2 · Jun 14, 2022 · US
Use of cannabinoids in the treatment of epilepsy
US-11311498-B2 · Apr 26, 2022 · US
Use of cannabinoids in the treatment of epilepsy
US-2022000800-A1 · Jan 6, 2022 · US
Use of cannabinoids in the treatment of epilepsy
US-2021401771-A1 · Dec 30, 2021 · US
Use of cannabidiol in the treatment of epilepsy
US-2021330636-A1 · Oct 28, 2021 · US
Use of cannabinoids in the treatment of epilepsy
US-11154517-B2 · Oct 26, 2021 · US
Use of cannabinoids in the treatment of epilepsy
US-11154516-B2 · Oct 26, 2021 · US
Use of cannabinoids in the treatment of epilepsy
US-11096905-B2 · Aug 24, 2021 · US
Use of cannabinoids in the treatment of epilepsy
US-2021244685-A1 · Aug 12, 2021 · US
Use of cannabinoids in the treatment of epilepsy
US-2021196651-A1 · Jul 1, 2021 · US
Use of cannabinoids in the treatment of epilepsy
US-10966939-B2 · Apr 6, 2021 · US
Use of cannabinoids in the treatment of epilepsy
US-2021093581-A1 · Apr 1, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Gw Res Ltd | 38 |
| Gw Pharma Ltd | 22 |
| Univ New York | 5 |
| Gw Res Ltd | 1 |
| Broad Inst Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P25/08 | 61 |
| A61K31/658 | 60 |
| A61K31/05 | 60 |
| A61K45/06 | 60 |
| A61K36/185 | 58 |